Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysisAlberto Martini, Andrea Necchi, Laura Marandino et al.|Cancer Treatment Reviews|2022Cited by 34
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical CystectomyAlberto Martini, Marco Moschini, Luca Afferi et al.|The Journal of Urology|2021Cited by 22
The immune‐related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: analysis of individual patient data from IMvigor210 and IMvigor211 trialsDaniele Robesti, Alberto Martini, Luigi Nocera et al.|British Journal of Urology|2023Cited by 8